Welcome to our dedicated page for Cross Ctry Healthcare news (Ticker: CCRN), a resource for investors and traders seeking the latest updates and insights on Cross Ctry Healthcare stock.
Cross Country Healthcare, Inc. (Nasdaq: CCRN) is a market-leading, tech-enabled workforce solutions and advisory firm focused on healthcare, homecare, and education markets. The CCRN news feed on Stock Titan aggregates company announcements, earnings releases, transaction updates, and other material developments drawn from Cross Country’s own press releases and regulatory disclosures.
Investors following CCRN news will see quarterly and annual financial results, where the company reports performance for its Nurse and Allied Staffing and Physician Staffing segments, as well as updates on Homecare Staffing and Cross Country Education. These releases often highlight trends in revenue, margins, cash flow, and balance sheet strength, along with commentary on operational efficiency initiatives and technology investments such as Intellify® and the Xperience™ app.
The news stream also covers strategic and corporate actions, including the previously announced Agreement and Plan of Merger with Aya Healthcare, subsequent stockholder approval, and the later termination of that merger agreement, as well as information about share repurchase activity and capital allocation decisions. Governance and leadership items, such as the CEO transition that brought co‑founder and Chairman Kevin C. Clark back into the President and Chief Executive Officer role, are disclosed through press releases and Forms 8‑K and are reflected in the news flow.
In addition, Cross Country Healthcare periodically publishes thought leadership and survey-based reports, such as its "Beyond the Bedside: The State of Nursing" study, which examines stress, burnout, and staffing challenges in the nursing profession. These items provide context on broader workforce issues that intersect with the company’s service offerings.
By monitoring the CCRN news page, readers can review a consolidated view of Cross Country Healthcare’s public communications, from financial performance and strategic transactions to leadership changes and industry research, all in one place.
Cross Country Healthcare (Nasdaq: CCRN) reported Q1 2026 results for the quarter ended March 31, 2026. Consolidated revenue was $241.1 million (down 18% year-over-year, up 2% sequentially). Consolidated gross profit margin was 19.7%. Net loss attributable to common stockholders was $4.3 million. Adjusted EBITDA was $3.9 million (1.6% margin). The company closed the quarter with $105.6 million cash, no debt, repurchased ~650,000 shares (~2.1%), and signed four new MSP/VMS agreements. The company entered into a merger agreement with Knox Lane parent entity; if consummated, CCRN would be taken private and delisted.
Cross Country Healthcare (NASDAQ: CCRN) agreed to be acquired by Knox Lane for $13.25 per share in an all-cash transaction valuing the company at $437 million. The deal implies a ~31% premium to the May 6, 2026 close and a ~45% premium to the 90-day VWAP.
The transaction is expected to close in Q3 2026, is subject to stockholder and regulatory approvals, and will result in Cross Country Healthcare becoming a privately held platform that will cease trading on Nasdaq.
Cross Country Healthcare (NASDAQ: CCRN) and Florida Atlantic University released Purpose Under Pressure: The State of Nursing in 2026, a national survey of more than 2,000 nurses and nursing students highlighting workforce pressures and retention priorities.
Key findings: 83% entered nursing to make a meaningful impact; burnout rose to 67%; pay/benefits concerns rose to 53%; 49% feel undervalued; 62% want flexibility. The report calls for staffing, scheduling, compensation and career-support changes.
Cross Country Healthcare (Nasdaq: CCRN) marks its 40th anniversary and is accelerating investment in workforce intelligence by expanding embedded AI and predictive analytics across end-to-end contingent workforce operations.
The company is advancing Intellify, its workforce intelligence platform, to unify contingent labor, locums, compliance, scheduling, and analytics, and is extending capabilities into locums, home-based care, and education.
Cross Country (Nasdaq: CCRN) appointed Darrick Sogabe as Chief Product Officer effective April 23, 2026, to lead product strategy, platform innovation, and enterprise growth. Sogabe, an architect of Intellify, will advance the cloud-based workforce intelligence platform and integrate contingent labor, compliance, scheduling, analytics, and agentic AI.
The hire aligns with Cross Country's push to expand its technology portfolio, improve labor visibility for health systems, and scale predictive analytics and intelligent automation.
Cross Country (Nasdaq: CCRN) appointed Chris Tyrell as Chief Information Officer effective April 21, 2026, to lead enterprise technology, AI, automation, and platform strategy.
Tyrell brings 20+ years of technology leadership and will oversee infrastructure, systems modernization, platform integration, cybersecurity, and Intellify® scaling.
Cross Country Healthcare (Nasdaq: CCRN) will host its First Quarter 2026 earnings conference call on Thursday, May 7, 2026 at 5:00 P.M. ET. The company intends to release its earnings press release after market close on May 7.
The call will be webcast live at the investor website and is accessible by U.S. and international phone numbers; replays will be available May 7–21 on the company website and by telephone through a provided passcode.
Cross Country Healthcare (NASDAQ: CCRN) announced a community partnership with Open Hearts for Orphans on March 10, 2026, to support vulnerable children and families through employee engagement, awareness-building, and strategic initiatives. The collaboration emphasizes people-centered values and a shared goal of creating measurable local and regional impact.
Cross Country Healthcare (Nasdaq: CCRN) reported Q4 2025 revenue of $236.8M (-24% YoY, -5% QoQ) and full-year 2025 revenue of $1.054B (-22% YoY). Q4 net loss was $82.9M driven by a $77.9M goodwill impairment and a $29.6M valuation allowance. Adjusted EBITDA was $4.1M (1.7% margin). Company ended 2025 with $108.7M cash, no debt, repurchased 0.8M shares for $6.5M, and provided Q1 2026 guidance of $235M–$240M revenue with adjusted EBITDA of $4M–$5M.
Cross Country Healthcare (Nasdaq: CCRN) will attend two investor conferences in March 2026. Company executives William J. Burns, EVP & Chief Financial Officer, and Josh Vogel, VP Investor Relations, will hold one-on-one meetings at Truist Virtual Human Capital (March 12-13) and Oppenheimer MedTech & Services (March 16-19).
No formal presentation will be delivered at either event.